Education / Graduate Medical Education / Prospective Fellows / Infectious Diseases Fellowship / Research / Peer Reviewed Publications

Recent Peer Reviewed Publications

1. Tenforde MW
2. Ujamaa D
3. Talbot HK
4. O'Halloran AC
5. Chai SJ
6. Sachdev D
7. Armistead I
8. Alden NB
9. Meek J
10. Yousey-Hindes K
11. Witt LS
12. Openo KP
13. Ryan PA
14. Monroe ML
15. Kim S
16. Nunez VT
17. Lynfield R
18. McMahon M
19. McCahon C
20. Bleecker M
21. Barney G
22. Mahoney K
23. Tesini BL
24. Gaitan MA
25. Ingabire-Smith D
26. Moran NE
27. Sutton M
28. Hendrick A
29. Schaffner W
30. Chatelain R
31. Swain A
32. Garg S
33. Bozio CH
Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirmed influenza, Influenza Hospitalization Surveillance Network, 2022-2024.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026 May 20.
1. Zimmer A
2. Zagari J
3. Sudnik P
4. Yamshchikov A
5. Lopa S
6. Spitznogle S
7. DePasquale W
8. Donnelly D
9. Dobrzynski D
10. Stern J
11. Shulder S
12. Quartuccio KS
Cephalosporin use and patient outcomes following removal of penicillin-cephalosporin cross-reactivity alerts from the electronic health record.; Antimicrobial agents and chemotherapy. 2026 May 15.
1. Pecora N
2. Dumyati G
3. Holt K
4. Taffner S
5. Tesini B
A Genomic Analysis of Community-Associated C. Difficile Infection Demonstrates Integration With National and International Strain Clusters and Limited Direct Transmission.; The Journal of infectious diseases. 2026 Mar 30.
1. Chow B
2. Mena Lora AJ
3. Luther VP
4. Neyra JA
5. Acharya K
6. Alsoubani M
7. Berto CG
8. Cariello P
9. Dobrzynski D
10. Donaghy H
11. Jamarkattel S
12. Kaltsas A
13. Kostka J
14. Medina-Garcia L
15. Murphy H
16. Sellers C
17. Slosar-Cheah M
18. Stapleton A
Bridging the Gap: A Needs Assessment of Resources and Support for International Medical Graduates Navigating Visa-related Career Decisions in Infectious Diseases.; Open forum infectious diseases; Vol 13(4), pp. ofag183. 2026 Mar 25.
1. Branche AR
The Renaissance of RSV Diagnosis: How Understanding Burden can Inform Clinical Practice and Demonstrate the Benefit of Vaccines.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026 Mar 06.
1. Lima NS
2. McCormick L
3. Li S
4. Wake CG
5. Subramanian R
6. Spangler A
7. Pinto Y
8. Catalano W
9. Henry AR
10. Laboune F
11. Teng IT
12. Lyke KE
13. Atmar RL
14. Deming ME
15. Jackson LA
16. Branche AR
17. Rostad CA
18. Martin JM
19. Johnston CM
20. Rupp RE
21. Kottkamp AC
22. Brady RC
23. Backer M
24. Edupuganti S
25. Posavad CM
26. Roberts PC
27. Kwong PD
28. Andrews S
29. Schramm CA
30. Douek DC
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.; Science translational medicine; Vol 18(838), pp. eaeb9837. 2026 Feb 25.
1. Falsey AR
2. Peterson DR
3. Walsh EE
4. Bhattacharya S
5. Baran AM
6. Chu C
7. Branche AR
8. Croft DP
9. Peasley M
10. Corbett AM
11. Ashton J
12. Mariani TJ
A four-gene signature from blood to exclude bacterial etiology of lower respiratory tract infection in adults.; Nature communications; Vol 16(1), pp. 10383. 2025 Nov 24.
1. Whitaker JA
2. Collins MH
3. Rebolledo PA
4. Dobrzynski D
5. Samanovic MI
6. Hoft D
7. Stephens DS
8. Rostad CA
Future Goals and Long-term Vision of the Infectious Diseases Clinical Research Consortium/Vaccine and Treatment Evaluation Unit Network.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 81(Supplement_2), pp. S137-S146. 2025 Oct 10.
1. Dobrzynski DM
2. Graciaa DS
3. Babu TM
4. Coler RN
5. Paulsen GC
6. Hoft DF
7. Frey SE
8. Edwards KM
9. Jackson LA
10. Chen WH
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 81(Supplement_2), pp. S125-S136. 2025 Oct 10.
1. Jano K
2. Babu TM
3. Kottkamp AC
4. Rebolledo PA
5. Parameswaran L
6. Wiley Z
7. Branche AR
8. Kotloff K
Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 81(Supplement_2), pp. S117-S124. 2025 Oct 10.
1. Mbuya W
2. Horvath A
3. Held K
4. Maganga L
5. Hoelscher M
6. Bekker LG
7. Duerr A
8. Moodie Z
9. Churchyard G
10. Keefer MC
11. Viegas E
12. Moog C
13. Geldmacher C
14. Chachage M
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses.; Frontiers in immunology; Vol 16, pp. 1601865. 2025 Sep 23.
1. O'Halloran A
2. Habeck JW
3. Gilmer M
4. Threlkel R
5. Chai SJ
6. Hall B
7. Armistead I
8. Alden NB
9. Meek J
10. Yousey-Hindes K
11. Openo KP
12. Witt LS
13. Monroe ML
14. Ryan PA
15. Leegwater L
16. Kim S
17. McMahon M
18. Lynfield R
19. Harbi K
20. Khalifa M
21. McCahon C
22. Barney G
23. Anderson BJ
24. Felsen CB
25. Tesini BL
26. Moran NE
27. Ingabire-Smith D
28. Sutton M
29. Hendrick MA
30. Schaffner W
31. Talbot HK
32. George A
33. Zahid H
34. Garg S
35. Bozio CH
Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.; MMWR. Morbidity and mortality weekly report; Vol 74(34), pp. 529-537. 2025 Sep 11.
1. Diemert DJ
2. Graciaa DS
3. Zhang B
4. Rouphael NG
5. Branche AR
6. Martin TCS
7. Jackson LA
8. Presti RM
9. Kamidani S
10. Mahgoub SM
11. Babu TM
12. Magaret CA
13. Simon V
14. van Bakel H
15. Roberts PC
16. Beigel JH
17. Gilbert PB
18. Follmann D
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.; Vaccine; Vol 64, pp. 127718. 2025 Sep 09.
1. Parks KR
2. Moodie Z
3. Allen MA
4. Yen C
5. Furch BD
6. MacPhee KJ
7. Ozorowski G
8. Heptinstall J
9. Hahn WO
10. Zheng Z
11. Lu H
12. Grant S
13. Domin E
14. Duff MO
15. Seese A
16. Marini-Macouzet C
17. Ballweber-Fleming L
18. Lee WH
19. Cottrell CA
20. Liguori A
21. Georgeson E
22. Alavi N
23. Kubitz M
24. Phelps N
25. Seaton KE
26. Cohen KW
27. Anderson MA
28. Mondal K
29. Laufer DS
30. Kublin JG
31. Ward AB
32. Hyrien O
33. De Rosa SC
34. Himansu S
35. Leav B
36. Reuter C
37. Tomaras GD
38. Montefiori D
39. Walsh SR
40. Frank I
41. Sobieszczyk ME
42. Goepfert PA
43. Stephenson KE
44. Baden LR
45. Van Tieu H
46. Keefer MC
47. Clark J
48. Riddler SA
49. Schief WR
50. McElrath MJ
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.; Science translational medicine; Vol 17(809), pp. eady6831. 2025 Jul 30.
1. Wang D
2. Pham HT
3. Chai S
4. Hoover C
5. Armistead I
6. Kawasaki B
7. Yousey-Hindes KM
8. Meek J
9. Witt LS
10. Openo KP
11. Brooks A
12. Rojewski S
13. Henderson JJ
14. Martin E
15. Mumm E
16. Salazar-Sanchez Y
17. Paloma Shaw Y
18. Keating F
19. Rowe A
20. Popham K
21. Tesini BL
22. Novak A
23. Sutton M
24. Schaffner W
25. Talbot HK
26. Hill M
27. Zahid H
28. Havers FP
29. Patton ME
Characteristics of Children Aged 0 to 23 Months Hospitalized With Respiratory Syncytial Virus.; Pediatrics. 2025 Jul 25.